Objective: There is no standardized endoscopic description of upper gastrointestinal [UGI] disease in Crohn's disease [CD]. We prospectively applied the Simple Endoscopic Score for CD [SES-CD] to the UGI tract as a planned sub-study of the multicentre prospective ImageKids study. We aimed to assess the utility of the UGI-SES-CD and its clinical significance in paediatric CD. Design: Patients underwent an oesophagogastroduodenoscopy [EGD], ileocolonoscopy, and magnetic resonance enterography [MRE] with explicit clinical data recorded. SES-CD was scored at each region [oesophagus, stomach body, antrum, and duodenum]. Half of the patients were followed for 18 months, when a repeat MRE was performed. Results: A total of 202 children were included 56% males, mean age 11.5 ± 3. In all, 81 patients were followed for 18 months and no association was identified between initial UGI SES-CD and markers of disease course such as surgery, MRE assessment, or treatment escalation. Conclusion: UGI-SES-CD is an easily reported objective scoring system and is associated with a more severe disease phenotype but not with disease course.
Introduction
Routine performance of oesophagogastroduodenoscopy [EGD] in patients with Crohn's disease [CD] may reveal upper gastrointestinal [UGI] inflammation in 30-64% of patients. [1] [2] [3] [4] [5] [6] Microscopic UGI involvement is also well documented in ulcerative colitis [UC], [6] [7] [8] but visible endoscopic lesions are less frequent, ranging between 0% and 21%, with a relatively higher prevalence noted in paediatric than in adult studies. 6, 9, 10 Studies suggest that UGI inflammation in CD may be associated with earlier disease onset and a more severe phenotype. 1, 11 Hence performing EGD may not only assist in the accurate diagnosis of inflammatory bowel diseases [IBD] but may also predict disease course while directing appropriate treatment strategy. The revised Porto criteria include EGD as a mandatory examination along with colonoscopy at disease onset in all children with suspected IBD. 12 However, unlike colonoscopy and capsule endoscopy, there is no accepted scoring system to standardise UGI findings, in children or in adults. This leads to difficulty in accurate reporting and comparison of UGI findings, and limits the ability to better understand the significance of this location in CD.
The SES-CD is a simple, reproducible, and validated endoscopic score for describing ileocolonoscopic findings in CD. 13 It is composed of four domains [ulcer size, ulcerated surface, affected surface, and narrowing] scored at each colonic segment. In order to aid classification of UGI involvement we hypothesised that the same scoring system could be applied to the UGI region [termed UGI-SES-CD; Appendix] to provide a more standardised descriptive measure and meaningful assessment of UGI CD. As a pre-planned sub-study of the ImageKids multicentre study, we aimed to prospectively assess the validity of UGI-SES-CD in this cohort on various constructs of disease activity and disease course over 18-month follow-up. 12 were enrolled at disease onset or thereafter if they required ileocolonoscopy, EGD, and MRE as part of clinical care. A total of 240 children were enrolled, of whom 120 were followed through 18 months, when a second MRE examination was repeated. Crohn's management was as per treating physician, with no involvement of the ImageKids protocol in treatment plan.
Methods

ImageKids
Data collection
Explicit clinical findings, including physician global assessment [PGA] of both inflammation and bowel damage, weighted Paediatric Crohn's Disease Activity Index [wPCDAI] , and serum biochemical tests were recorded at enrolment and, in the longitudinal cohort, also at 6, 12, and 18 months thereafter. Stool was obtained for calprotectin within 2 weeks of endoscopic assessment. MRE assessment of disease severity, performed within 2 weeks of the endoscopic assessment, was captured using an overall radiologist assessment of bowel inflammation and, separately, of bowel damage. PGA and radiologist assessment were recorded both categorically [ranging from deep remission to severe disease activity, and from no damage to severe extensive damage, respectively] and on a visual analogue scale [VAS], a linear scale in which severity is assessed as a mark along a 100-mm line.
2.3.
Upper gastrointestinal simplified endoscopic activity score for Crohn's disease UGI-SES-CD was applied using the same criteria as for ileocolonoscopy, with the items relating to size of ulcers, ulcerated surface, affected surface, and narrowing, scored from 0-3, in four regions: oesophagus, stomach body, antrum, and duodenum [Appendix: UGI-SES-CD score card]. A user's guide determined that obvious Helicobacter pylori-related antritis, coeliac-related scalloping, or obvious reflux oesophagitis were not to be included in the endoscopic score.
Validity is the degree to which the instrument measures the concept that it purports to measure and includes construct, predictive, and criterion validity.
14 In this study we used construct validation based on association between the UGI-SES-CD score and other constructs of disease activity, including clinical assessment [wPC-DAI and PGA], ileocolonoscopic SES-CD, faecal calprotectin, serum inflammatory markers, serum albumin, and MRE assessment of both inflammation and bowel damage. Growth failure was based on age-adjusted height velocity over 6-12 months preceding the assessment. We also used predictive validity by associating the UGI-SES-CD with disease course in the longitudinal cohort, including the need for treatment escalation, surgeries, or endoscopic interventions, as well as worsening clinical markers of disease state as measured by PGA and wPCDAI, and worsening radiological assessment of bowel damage and inflammation on follow-up MRE.
Statistics
Data are reported as proportions (with corresponding 95% confidence intervals [95% CI]), means ± standard deviation, or medians (interquartile range [IQR]) as appropriate. Continuous data were compared using Student's t test or the Wilcoxon rank sum test, as per the distribution normality. Spearman's or Pearson's correlations were used as appropriate. Categorical variables were compared using chi-square or Fisher's exact tests, as appropriate. Statistical analyses were performed using SPSS for windows V21.0, with p < 0.05 taken as the significance threshold. The ethics committees of all centres approved this study. Consent, and when appropriate also assent, was obtained in all cases.
Results
A total of 247 children were potentially eligible for this study, including seven patients who were excluded from the original ImageKids study due to protocol violations unrelated to this analysis. Of these, 202 underwent EGD assessment and were included in our analysis; 81 of these also had a full 18-month follow-up as per protocol [ Table 1 ]. UGI-SES-CD scores were recorded in all included patients with no missing data. 
UGI-SES-CD score distribution
Construct validation
UGI-SES-CD ≥1 was associated with a more active disease in our cohort, as reflected by most constructs including wPCDAI, ileocolonoscopic SES-CD, gastroenterologist PGA of inflammation, radiologist MRE global assessment of intestinal damage, and faecal calprotectin [ Table 2 ]. There was a trend to lower serum albumin.
Haemoglobin, erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], MRE global assessment of inflammation, and presence of growth failure were not significantly different between the two groups [ Table 2 ]. These associations were reassessed using different cut-offs of UGI SES-CD, including ≥3, ≥5, ≥7, and ≥10, with only UGI SES-CD ≥3 retaining the above associations with markers of disease severity; however, this sensitivity analysis is limited by the smaller numbers of children with higher UGI SES-CD scores. Similarly, an attempt to perform subanalysis considering only the presence of ulcerations was hampered by the small sample size in each category, and thus was not pursued further.
Predictive validity
The presence of UGI SES-CD ≥1 at baseline was not predictive of disease course or complications in our cohort [ Table 3 ]. The same was true for other aforementioned cut-off values of the index. Similarly, no consistent association was apparent between the presence of ulcers and disease course [data not shown]. 
Discussion
With the increasing use of gastroscopy in the evaluation of IBD, UGI involvement has been recognised as a frequent finding, particularly in CD. The described prevalence of UGI involvement in CD varies widely from 30% to 64% in CD patients undergoing routine EGD. [1] [2] [3] [4] [5] This variability may be largely attributed to the unstandardised definition of UGI CD. 15 In this study we report the application of the SES-CD scoring system to the UGI tract in order to standardise its assessment. We scored the SES-CD features in each of four major regions of the UGI: oesophagus, stomach body, antrum, and duodenum. In our study, UGI-SES-CD was easily scored without any missing data in any of the included patients.
We found that almost half of children with CD have some endoscopic abnormalities in the UGI tract, of whom 63% had duodenal involvement, 22% had oesophageal involvement, and 70% had either oesophageal and/or duodenal involvement. Of those with UGI involvement, 68% had overt ulcerations anywhere in the UGI tract, with 53% in theoesophagus and/or the duodenum. Most of the ulcerations were scored as aphthous ulcerations, and no patient scored the category of a very large ulcer. Additionally no patient had narrowing in our cohort. However, deeper ulcerations in the UGI, as well as pyloric, duodenal, and even oesophageal stenosis, have been reported. [16] [17] [18] [19] [20] Therefore we elected to maintain the structure of the original SES-CD for simplicity, and because all items in the SES-CD seem to appropriately describe the typical features of UGI CD without the need for specific modifications or additions.
We found that the UGI-SES-CD score was associated with most constructs of disease severity, lending support to its validity. 21 Whereas our study corroborates the association between UGI CD and more severe disease presentation, no association was identified between UGI CD and disease course. Although this might be conceived as a negative sign for UGI-SES-CD validity, it is not necessarily so, since conflicting findings have been previously reported on the association between UGI findings and disease progression. A prospective Chinese study of 132 patients with CD demonstrated that those with UGI CD had higher rates of stricturing and penetrating disease over a 5-year period [47% vs 19% and 30% vs 4%, respectively; p < 0.0001] and a higher probability of subsequent hospitalisation. 21 However this study did not distinguish between findings above or below the ligament of Treitz [L4a and L4b according to the Paris classification 22 ]. Furthermore gastroscopy was only performed as clinically indicated; hence the significance of UGI CD may be overstated in this study. The aforementioned paediatric study, which specifically analysed only oesophageal CD, did not find any difference in need for surgical intervention throughout the mean 3.5-year follow-up period. 11 In contrast, a case series and literature review of oesophageal CD by Weinstein et al. 23 raised the suggestion of possible poorer response to corticosteroid treatment and higher corticosteroid dependency in these patients. Although our study is large by any paediatric standard, the sample size and follow-up may be insufficient to accurately assess responsiveness of the UGI SES-CD to predict disease course.
An unavoidable limitation of any potential scoring system of the UGI tract is the relatively common endoscopic findings unrelated to CD, such as Helicobacter pylori gastritis, reflux oesophagitis, and coeliac disease, which may hamper the accuracy of the scoring system. We determined in the user's guide that, where clearly identified, these findings should not be regarded in the UGI-SES-CD score and should be scored as normal. When the contribution of the CD cannot be clearly excluded, the finding should be scored as a real CD finding. Since the user's guide was developed after enrolment commenced, we do not have data to present on the rate of these findings in our cohort.
In summary, our data confirm that endoscopic UGI findings are very common in CD, and further support the recommendation of routine UGI endoscopy in the initial workup of all potential IBD cases. 12, 24 We propose a formalised scoring system, which has been internally validated, correlating with various clinically relevant constructs. Consequently, the UGI-SES-CD should enable standardisation among studies of the clinical significance of UGI CD.
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